Treatment of an Alveolar Rhabdomyosarcoma Allograft with Recombinant Myxoma Virus and Oclacitinib.
- Published in:
- Oncolytic Virotherapy, 2020, v. 9, p. 17, doi. 10.2147/OV.S252727
- By:
- Publication type:
- Article
Works matching IS 22531572 AND DT 2020 AND VI 9
Results: 2
1
2
Virus–Receptor Interactions and Virus Neutralization: Insights for Oncolytic Virus Development.
- Published in:
- Oncolytic Virotherapy, 2020, v. 9, p. 1, doi. 10.2147/OV.S186337
- By:
- Publication type:
- Article